Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 4/2013

01-08-2013 | Case Report

Everolimus-induced Pneumonitis after Drug-eluting Stent Implantation: A Case Report

Authors: Susumu Sakamoto, Naoshi Kikuchi, Atsuo Ichikawa, Go Sano, Keita Satoh, Keishi Sugino, Kazutoshi Isobe, Yujiro Takai, Kazutoshi Shibuya, Sakae Homma

Published in: CardioVascular and Interventional Radiology | Issue 4/2013

Login to get access

Abstract

Despite the wide use of everolimus as an antineoplastic coating agent for coronary stents to reduce the rate of restenosis, little is known about the health hazards of everolimus-eluting stents (EES). We describe a case of pneumonitis that developed 2 months after EES implantation for angina. Lung pathology demonstrated an organizing pneumonia pattern that responded to corticosteroid therapy. Although the efficacy of EES for ischemic heart disease is well established, EES carries a risk of pneumonitis.
Literature
1.
go back to reference Howard JE, Murat TR, Richard D et al (2003) Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349:847–858CrossRef Howard JE, Murat TR, Richard D et al (2003) Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349:847–858CrossRef
2.
go back to reference Motzer RJ, Escudier B, Oudard S et al (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372:449–456PubMedCrossRef Motzer RJ, Escudier B, Oudard S et al (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372:449–456PubMedCrossRef
3.
go back to reference Stone GW, Midei M, Newman W et al (2008) Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 299:1903–1913PubMedCrossRef Stone GW, Midei M, Newman W et al (2008) Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 299:1903–1913PubMedCrossRef
4.
go back to reference White DA, Schwartz LH, Dimitrijevic S et al (2009) Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001). J Thorac Oncol 4:1357–1363PubMedCrossRef White DA, Schwartz LH, Dimitrijevic S et al (2009) Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001). J Thorac Oncol 4:1357–1363PubMedCrossRef
5.
go back to reference White DA, Camus P, Endo M et al (2010) Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma. Am J Respir Crit Care Med 182:396–403PubMedCrossRef White DA, Camus P, Endo M et al (2010) Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma. Am J Respir Crit Care Med 182:396–403PubMedCrossRef
6.
go back to reference Frija J, Joly D, Knebelmann B, Dusser D et al (2012) Everolimus-related organizing pneumonia: a report establishing causality. Invest New Drugs 30:1244–1247PubMedCrossRef Frija J, Joly D, Knebelmann B, Dusser D et al (2012) Everolimus-related organizing pneumonia: a report establishing causality. Invest New Drugs 30:1244–1247PubMedCrossRef
7.
go back to reference Carreño CA, Gadea M (2007) Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation. Transplant Proc 39:505–594CrossRef Carreño CA, Gadea M (2007) Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation. Transplant Proc 39:505–594CrossRef
8.
go back to reference Champion L, Stern M, Israel-Biet D et al (2006) Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med 144:505–509PubMedCrossRef Champion L, Stern M, Israel-Biet D et al (2006) Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med 144:505–509PubMedCrossRef
9.
go back to reference Kato K, Fukuda S, Tetsuo Fujimaki T et al (2009) Paclitaxel-induced interstitial pneumonia after drug-eluting stent implantation: report of a fatal case. Inter Med 48:911–913CrossRef Kato K, Fukuda S, Tetsuo Fujimaki T et al (2009) Paclitaxel-induced interstitial pneumonia after drug-eluting stent implantation: report of a fatal case. Inter Med 48:911–913CrossRef
10.
go back to reference Fujimaki T, Kato K, Fukuda S et al (2011) Acute interstitial pneumonitis after implantation of paclitaxel-eluting stents: a report of two fatal cases. Int J Cardiol 148:21–24CrossRef Fujimaki T, Kato K, Fukuda S et al (2011) Acute interstitial pneumonitis after implantation of paclitaxel-eluting stents: a report of two fatal cases. Int J Cardiol 148:21–24CrossRef
Metadata
Title
Everolimus-induced Pneumonitis after Drug-eluting Stent Implantation: A Case Report
Authors
Susumu Sakamoto
Naoshi Kikuchi
Atsuo Ichikawa
Go Sano
Keita Satoh
Keishi Sugino
Kazutoshi Isobe
Yujiro Takai
Kazutoshi Shibuya
Sakae Homma
Publication date
01-08-2013
Publisher
Springer New York
Published in
CardioVascular and Interventional Radiology / Issue 4/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-012-0477-y

Other articles of this Issue 4/2013

CardioVascular and Interventional Radiology 4/2013 Go to the issue